Osteoporotic fracture is a clinical problem resulting in significant morbidity and mortality.The main treatment for osteoporosis is bisphosphonate therapy.Bisphosphonates can inhibit the bone resorption by osteoclasts,inhibit bone alteration,and maintain bone mass.In recent years,basic and clinical studies have not found evidence that the use of bisphosphonates for the inhibition of fracture healing.Therefore,for the patients with confirmed osteoporotic fracture,bisphosphonate should be used to reduce the risk of re-fracture.The authors summarize the related studies in the bisphosphonate intervention for osteoporotic fracture and recommend postoperative use of bisphosphonate for osteoporotic fracture.
智信,陈晓,苏佳灿.. 重视双膦酸盐在骨质疏松性骨折术后的应用[J]. 中华创伤杂志, 2020, 36(1): 14-17.
Zhi Xin,Chen Xiao,Su Jiacan.. Attach great importance to postoperative use of bisphosphonate following osteoporotic fracture. CHINESE JOURNAL OF TRAUMA, 2020, 36(1): 14-17.